DK1289931T3 - Dobbeltsalte af fumarsyre med et carnitin og en aminosyre samt kosttilskud, diættilskud og lægemidler indeholdende samme - Google Patents
Dobbeltsalte af fumarsyre med et carnitin og en aminosyre samt kosttilskud, diættilskud og lægemidler indeholdende sammeInfo
- Publication number
- DK1289931T3 DK1289931T3 DK01934310T DK01934310T DK1289931T3 DK 1289931 T3 DK1289931 T3 DK 1289931T3 DK 01934310 T DK01934310 T DK 01934310T DK 01934310 T DK01934310 T DK 01934310T DK 1289931 T3 DK1289931 T3 DK 1289931T3
- Authority
- DK
- Denmark
- Prior art keywords
- supplements
- carnitine
- amino acid
- well
- same
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title abstract 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 title 2
- 229960004203 carnitine Drugs 0.000 title 1
- 239000001530 fumaric acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 239000013589 supplement Substances 0.000 title 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 abstract 1
- IGQBPDJNUXPEMT-SNVBAGLBSA-N isovaleryl-L-carnitine Chemical compound CC(C)CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C IGQBPDJNUXPEMT-SNVBAGLBSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2000RM000322A IT1317042B1 (it) | 2000-06-14 | 2000-06-14 | Fumarati doppi di una carnitina e creatina, e integratori alimentari,dietetici e farmaci che li contengono. |
| EP01934310A EP1289931B1 (en) | 2000-06-14 | 2001-04-24 | Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| PCT/IT2001/000199 WO2001096281A1 (en) | 2000-06-14 | 2001-04-24 | Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1289931T3 true DK1289931T3 (da) | 2005-04-25 |
Family
ID=11454785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01934310T DK1289931T3 (da) | 2000-06-14 | 2001-04-24 | Dobbeltsalte af fumarsyre med et carnitin og en aminosyre samt kosttilskud, diættilskud og lægemidler indeholdende samme |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6730693B2 (cs) |
| EP (1) | EP1289931B1 (cs) |
| JP (1) | JP4430301B2 (cs) |
| KR (1) | KR100596732B1 (cs) |
| CN (1) | CN1326832C (cs) |
| AT (1) | ATE286016T1 (cs) |
| AU (1) | AU783291B2 (cs) |
| BR (1) | BR0111579A (cs) |
| CA (1) | CA2412055C (cs) |
| CZ (1) | CZ302371B6 (cs) |
| DE (1) | DE60108122T2 (cs) |
| DK (1) | DK1289931T3 (cs) |
| ES (1) | ES2233635T3 (cs) |
| HU (1) | HU228837B1 (cs) |
| IT (1) | IT1317042B1 (cs) |
| MX (1) | MXPA02012265A (cs) |
| PL (1) | PL203876B1 (cs) |
| PT (1) | PT1289931E (cs) |
| WO (1) | WO2001096281A1 (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2316430T3 (pl) | 2004-10-08 | 2012-11-30 | Forward Pharma As | Kompozycje farmaceutyczne o kontrolowanym uwalnianiu, zawierające ester kwasu fumarowego |
| EP1915334A2 (en) * | 2005-07-07 | 2008-04-30 | Aditech Pharma AB | Novel salts of fumaric acid monoalkylesters and their pharmaceutical use |
| CN101209975B (zh) * | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
| CN102369001A (zh) | 2009-01-09 | 2012-03-07 | 前进制药公司 | 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂 |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| KR102085557B1 (ko) | 2013-03-14 | 2020-03-06 | 엘커메스 파마 아일랜드 리미티드 | 푸마레이트의 프로드럭 및 다양한 질환을 치료하는데 있어서의 이들의 용도 |
| JP6337135B2 (ja) | 2014-02-24 | 2018-06-06 | アルカーメス ファーマ アイルランド リミテッド | フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用 |
| CN118638020B (zh) * | 2024-08-08 | 2024-11-19 | 杭州海尔希畜牧科技有限公司 | L-天门冬氨酸l(-)肉碱(1:1)的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0150688B1 (en) * | 1983-12-28 | 1987-04-22 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
| FR2635264B1 (fr) | 1988-08-12 | 1992-02-28 | Bellon Labor Sa Roger | Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine |
| IT1245699B (it) * | 1991-05-29 | 1994-10-14 | Sigma Tau Ind Farmaceuti | Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi |
| US5994581A (en) * | 1998-03-09 | 1999-11-30 | Amt Labs, Inc. | Carnitine creatinate |
-
2000
- 2000-06-14 IT IT2000RM000322A patent/IT1317042B1/it active
-
2001
- 2001-04-24 PL PL363511A patent/PL203876B1/pl unknown
- 2001-04-24 AT AT01934310T patent/ATE286016T1/de active
- 2001-04-24 CZ CZ20023949A patent/CZ302371B6/cs not_active IP Right Cessation
- 2001-04-24 JP JP2002510425A patent/JP4430301B2/ja not_active Expired - Lifetime
- 2001-04-24 KR KR1020027016899A patent/KR100596732B1/ko not_active Expired - Lifetime
- 2001-04-24 CN CNB018111092A patent/CN1326832C/zh not_active Expired - Lifetime
- 2001-04-24 US US10/297,843 patent/US6730693B2/en not_active Expired - Lifetime
- 2001-04-24 AU AU60603/01A patent/AU783291B2/en not_active Expired
- 2001-04-24 HU HU0301568A patent/HU228837B1/hu unknown
- 2001-04-24 DK DK01934310T patent/DK1289931T3/da active
- 2001-04-24 WO PCT/IT2001/000199 patent/WO2001096281A1/en not_active Ceased
- 2001-04-24 CA CA002412055A patent/CA2412055C/en not_active Expired - Lifetime
- 2001-04-24 BR BR0111579-0A patent/BR0111579A/pt not_active Application Discontinuation
- 2001-04-24 ES ES01934310T patent/ES2233635T3/es not_active Expired - Lifetime
- 2001-04-24 EP EP01934310A patent/EP1289931B1/en not_active Expired - Lifetime
- 2001-04-24 PT PT01934310T patent/PT1289931E/pt unknown
- 2001-04-24 DE DE60108122T patent/DE60108122T2/de not_active Expired - Lifetime
- 2001-04-24 MX MXPA02012265A patent/MXPA02012265A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1289931B1 (en) | 2004-12-29 |
| CN1326832C (zh) | 2007-07-18 |
| ITRM20000322A1 (it) | 2001-12-14 |
| EP1289931A1 (en) | 2003-03-12 |
| CZ20023949A3 (cs) | 2003-04-16 |
| BR0111579A (pt) | 2003-03-18 |
| CA2412055A1 (en) | 2001-12-20 |
| PT1289931E (pt) | 2005-03-31 |
| HUP0301568A3 (en) | 2004-12-28 |
| MXPA02012265A (es) | 2004-02-27 |
| US6730693B2 (en) | 2004-05-04 |
| KR100596732B1 (ko) | 2006-07-04 |
| HUP0301568A2 (hu) | 2003-08-28 |
| DE60108122D1 (de) | 2005-02-03 |
| HK1056549A1 (en) | 2004-02-20 |
| ITRM20000322A0 (it) | 2000-06-14 |
| ES2233635T3 (es) | 2005-06-16 |
| WO2001096281A1 (en) | 2001-12-20 |
| PL363511A1 (en) | 2004-11-29 |
| US20030171417A1 (en) | 2003-09-11 |
| HU228837B1 (en) | 2013-06-28 |
| JP2004503521A (ja) | 2004-02-05 |
| KR20030017536A (ko) | 2003-03-03 |
| CA2412055C (en) | 2009-02-03 |
| IT1317042B1 (it) | 2003-05-26 |
| CZ302371B6 (cs) | 2011-04-13 |
| ATE286016T1 (de) | 2005-01-15 |
| CN1436166A (zh) | 2003-08-13 |
| AU783291B2 (en) | 2005-10-13 |
| JP4430301B2 (ja) | 2010-03-10 |
| AU6060301A (en) | 2001-12-24 |
| PL203876B1 (pl) | 2009-11-30 |
| DE60108122T2 (de) | 2005-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0969744T3 (da) | Kosttilskud til forbedringer af celleenergetik | |
| DK1289931T3 (da) | Dobbeltsalte af fumarsyre med et carnitin og en aminosyre samt kosttilskud, diættilskud og lægemidler indeholdende samme | |
| DK1409449T3 (da) | Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse | |
| BR9809368A (pt) | Composições sólidas adequadas para administração oral compreendendo l-carnitina ou fumarato de magnésio de alcanoil-l-carnitina. | |
| PT1292570E (pt) | Sal de creatina que possui uma eficacia nutricional e terapeutica melhorada e composicoes que o contem | |
| WO2005123108A3 (en) | Advanced vitamins and protein based nutritional supplements | |
| WO2001091769A3 (en) | Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins | |
| NO20031261L (no) | Dyrefôrsupplement som inneholder D-pantotensyre og/eller dens salter, forbedret fremgangsmåte for fremstilling derav samt anvendelse derav | |
| DK1202956T3 (da) | Terapeutisk og/eller ernærngsmæssigt forstærkede derivater af aktive bestanddele og oralt indgivelsesbare præparater indeholdende de samme | |
| CA2285490A1 (en) | Composition for improvement of cellular nutrition and mitochondrial energetics | |
| DK1569635T3 (da) | Anvendelse af carnitiner til forebyggelse og/eller behandling af lidelser forårsaget af andropause | |
| MXPA03003799A (es) | Composiciones solidas apropiadas para la administracion oral que contienen sales no higroscopicas de l-carnitina y l-carnitinas de alcanoilo con cloruro de taurina y cloruro de glicina. | |
| BR9808461A (pt) | Método para composições sólidas adequadas para administração oral compreendendo sais não higroscópicos de l-carnitina e alcanoil-l-carnitina com ácido 2-aminoetassulfÈnico. | |
| ITRM20010029A0 (it) | Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per | |
| BR9808908A (pt) | Composições sólidas adequadas para administração oral que compreendem l-carnitina ou tartarato de alcanoil-l-carnitina colina | |
| PT1093451E (pt) | Composicoes solidas adequadas para administracao oral contendo sais nao-higroscopicos de l-carnitina e alcanoil-l-carnitinas | |
| Kurihara et al. | Mindo/3 Molecular-Orbital Calculations on the 6R-BH4 Molecule and Its Metabolic Precursors: Conformation and Activity | |
| PT1541041E (pt) | Composições farmacêuticas e/ou dietéticas contra o stresse | |
| DK0997453T3 (da) | Phenoxyisosmørsyreammoniumsalte og farmaceutiske formuleringer indeholdende dem | |
| EG24704A (en) | A method for the preparation of stable pharmaceutical compositions for intramusclar injection, combining folic acid with other vitamins in a single aqueous solution | |
| RU2001101615A (ru) | Препарат для лечения гепатоза животных |